HIIFS
AMED

Harel Insurance Investments & Financial Services’s Amedisys AMED Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-215
Closed -$37K – 708
2022
Q1 		$37K Sell
215
-18
-8% -$2.69K ﹤0.01% 559
2021
Q4 		$38K Buy
233
+83
+55% +$13.3K ﹤0.01% 627
2021
Q3 		$22K Buy
150
+60
+67% +$12.5K ﹤0.01% 612
2021
Q2 		$72K Buy
+90
New +$23.6K ﹤0.01% 686

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Harel Insurance Investments & Financial Services's AMED Position: Q2 2022 in Review

Harel Insurance Investments & Financial Services sold out of Amedisys (AMED) in Q2 2022, closing a stake of 215 shares — an estimated $37K sold.

Harel Insurance Investments & Financial Services first reported a position in AMED in Q2 2021 and held it in 4 quarters. The position peaked at $72K in Q2 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 215 Amedisys shares in Q2 2022, an estimated $37K.
  • Harel Insurance Investments & Financial Services first reported a position in Amedisys in Q2 2021 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Amedisys position peaked at $72K in Q2 2021.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2022, filed 19 Jul 2022.